GORE® Endovascular Stent Graft System with Active Control
GPTKB entity
Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:hospital
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Gore_Interventional_Devices
|
| gptkbp:benefits |
minimally invasive procedure
|
| gptkbp:clinical_trial |
conducted for efficacy
abdominal aortic aneurysm requires multidisciplinary approach regularly reviewed for best practices show positive outcomes supports ongoing innovation used in various vascular surgeries |
| gptkbp:competitors |
competes with other stent grafts
|
| gptkbp:complications |
risk of endoleak
|
| gptkbp:design |
modular design
|
| gptkbp:education |
important for informed consent
|
| gptkbp:educational_programs |
provided to enhance understanding
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:events |
necessary after implantation
|
| gptkbp:features |
Active Control technology
|
| gptkbp:feedback |
high satisfaction rates reported
collected for product improvement |
| gptkbp:has_specialty |
requires specialized training
|
| gptkbp:healthcare |
recommended at regular intervals
important for quality improvement integral to patient care. |
| https://www.w3.org/2000/01/rdf-schema#label |
GORE® Endovascular Stent Graft System with Active Control
|
| gptkbp:innovation |
continuously evolving
focus on improving patient care |
| gptkbp:is_effective_against |
demonstrated in studies
supported by clinical evidence |
| gptkbp:is_monitored_by |
required for complications
|
| gptkbp:is_used_for |
treatment of aortic aneurysms
|
| gptkbp:lifespan |
designed for durability
|
| gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
| gptkbp:market |
available in multiple sizes
|
| gptkbp:material |
gptkb:expanded_polytetrafluoroethylene_(e_PTFE)
|
| gptkbp:outcome |
conducted to assess performance
|
| gptkbp:partnerships |
collaborates with hospitals and clinics
|
| gptkbp:population |
adults
primarily older adults used in diverse populations |
| gptkbp:price |
considered cost-effective
|
| gptkbp:provides_information_on |
included in treatment guidelines
|
| gptkbp:recruitment |
based on anatomical criteria
|
| gptkbp:regulatory_compliance |
meets international standards
obtained in multiple countries |
| gptkbp:research |
ongoing for long-term effects
|
| gptkbp:safety_features |
generally safe with low complication rates
prioritized in design and use |
| gptkbp:shipping_options |
endovascular delivery
|
| gptkbp:specialties |
requires imaging guidance
transfemoral access evolving with technology advancements |
| gptkbp:system_requirements |
detailed in product literature
|
| gptkbp:technology |
radiopaque markers for visibility
|
| gptkbp:training |
available for healthcare providers
essential for effective use |
| gptkbp:treatment |
improved survival rates
evaluated through patient registries includes bleeding and infection monitored through registries typically rapid recovery |
| gptkbp:type |
stent graft
|